Research, Development & Investment

Alphapharm is committed to investing in research and development. This has been a key element of our success.

Currently, Alphapharm spends millions of dollars on research and product development. We're incredibly proud that this level of expenditure is well within the top tier for pharmaceutical companies in Australia. Our laboratory features the sophistication and technology of a world-class facility while our product development area boasts multiple suites, allowing many products to be developed simultaneously. In fact, Alphapharm makes hundreds of product submissions and updates each year, making us one of the TGA's largest clients. Our highly-qualified team is continually developing quality pharmaceuticals, which improves the availability of medicines to Australians.

Our commitment to local research, development and production offers a number of benefits beyond the obvious medical advantages for consumers. Alphapharm has significantly reduced Australia's reliance on imported medicines. We have also created hundreds of local skilled jobs. And we're able to provide some of this country's best science graduates with challenging and rewarding opportunities in Australia.

Moreover, we are continuing to invest. In the last few years we completed a $25 million expansion program which has doubled Alphapharm's capability of bringing quality and value medicines to the national and international community.